Frank Dekker partner in funded Horizon Europe project
The team of Prof. Frank Dekker of the Groningen Research Institute of Pharmacy (GRIP) participates in a Horizon Europe project that was recently funded. The project is called 'In Armor' and concerns the pre-clinical development of small molecule inhibitors of histone lysine deacetylases (HDAC) for the induction of antimicrobial peptides. The project will be performed by a consortium of 16 participants from 11 different European countries with a total budget of EUR 6 million. The Dekker team is funded with EUR 390,000 to work on the synthesis and characterization of a focussed collection of HDAC inhibitors that will be taken into pre-clinical development.
| Last modified: | 15 June 2023 4.23 p.m. |
More news
-
25 July 2025
Article highlight: New insight in how cells regulate gene activity
A new study, led by University of Groningen molecular biologist Danny Incarnato, identifies hundreds of shapeshifting regulatory RNA switches in E.coli bacteria and human cells.
-
23 July 2025
Dutch astronomers in Tenerife to test high-speed camera
Astronomers from the University of Groningen and the University of Amsterdam are on the Canary Island of Tenerife until 29 July to test a special camera to detect gamma rays emitted by extreme objects, such as supermassive black holes and supernovae....
-
17 July 2025
Veni-grants for eleven UG researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...